Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 4118 record(s)

Req # A-2023-001380

The rapid test supplier BTNX, Inc.'s, initial application to Health Canada to sell the COVID-19 antigen test with the device identifier COV-19CSHC.

Organization: Health Canada

202 page(s)
June 2024

Req # A-2023-001413

Natural Health Product (NHP) licence details for the products Zonnic Polar Mint, Zonnic Berry Frost, Zonnic Chill Mint, Zonnic Cranberry Fizz, Zonnic Tropic Breeze, which are contained under Natural Product Number (NPN): 80125630.

Organization: Health Canada

10 page(s)
June 2024

Req # A-2023-001415

The rapid test supplier BTNX, Inc.'s, initial application to Health Canada to sell the COVID-19 antigen test with the device identifier COV-19CHC.

Organization: Health Canada

90 page(s)
June 2024

Req # A-2023-001435

The application form for Abbott's Panbio COVID-19 Antigen Self-test - Interim Order (IO) 330161.

Organization: Health Canada

5 page(s)
June 2024

Req # A-2023-001447

The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate, which was accepted into review on or after March 1, 2022 but before December 1, 2022, and…

Organization: Health Canada

1 page(s)
June 2024

Req # A-2023-001454

The bio-waiver request submitted for the First Desmopressin Abbreviated New Drug Submission (ANDS); and a copy of Health Canada’s response to the bio-waiver request.

Organization: Health Canada

55 page(s)
June 2024

Req # A-2023-001479

The most recent Certified Product Information Document (CPID) submitted for the Degarelix Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

44 page(s)
June 2024

Req # A-2023-001529

Provide the name of the company (sponsor) who submitted the Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient estradiol (the Estradiol ANDS).

Organization: Health Canada

2 page(s)
June 2024

Req # A-2024-000093

All Health Canada records related to the following Monograph, “Active Hexose Correlated Compound – Granule (AHCC-FG)”: available online: https://webprod.hcsc.gc.ca/nhpid-bdipsn/monoReq.do?id=837&lang=eng.

Organization: Health Canada

121 page(s)
June 2024

Req # A-2024-000133

All documents regarding the reaction to the Minister of Mental Health and Addictions trip to the Middle East and meeting with President Mahmoud Abbas (https://nationalpost.com/news/world/israel-middle-east/melanie-joly-holding-hands-with-holocaust-…

Organization: Health Canada

2 page(s)
June 2024
Date modified: